Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (321-330 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesD R Holmes, E R Bates, N S Kleiman, et al.
Journal of the American College of Cardiology|March 1, 1993
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study GroupT C Wall, R M Califf, S G Ellis, et al.
The American Journal of Cardiology|February 1, 1991
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study GroupP Clemmensen, E R Bates, R M Califf, et al.
American Heart Journal|March 7, 2001
Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapyM Labinaz, M H Sketch, S G Ellis, et al.
American Heart Journal|February 26, 2000
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trialsS J Brener, S G Ellis, S K Sapp, et al.
American Heart Journal|June 30, 2000
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockadeD J Kereiakes, S D Berkowitz, A M Lincoff, et al.
American Heart Journal|February 1, 1990
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD W Muller, E J Topol, R M Califf, et al.
Circulation|June 1, 1992
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study GroupE J Topol, R M Califf, M Vandormael, et al.
Annals of Internal Medicine|May 1, 1988
Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysisR M Califf, W O'Neil, R S Stack, et al.
American Heart Journal|February 26, 2000
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigatorsD Hasdai, D R Holmes, D A Criger, et al.
Pageof 57

Showing results (321-330 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesD R Holmes, E R Bates, N S Kleiman, et al.
Journal of the American College of Cardiology|March 1, 1993
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study GroupT C Wall, R M Califf, S G Ellis, et al.
The American Journal of Cardiology|February 1, 1991
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study GroupP Clemmensen, E R Bates, R M Califf, et al.
American Heart Journal|March 7, 2001
Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapyM Labinaz, M H Sketch, S G Ellis, et al.
American Heart Journal|February 26, 2000
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trialsS J Brener, S G Ellis, S K Sapp, et al.
American Heart Journal|June 30, 2000
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockadeD J Kereiakes, S D Berkowitz, A M Lincoff, et al.
American Heart Journal|February 1, 1990
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupD W Muller, E J Topol, R M Califf, et al.
Circulation|June 1, 1992
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study GroupE J Topol, R M Califf, M Vandormael, et al.
Annals of Internal Medicine|May 1, 1988
Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysisR M Califf, W O'Neil, R S Stack, et al.
American Heart Journal|February 26, 2000
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigatorsD Hasdai, D R Holmes, D A Criger, et al.
Pageof 57